	The overlooked link between reproductive system disorders and depression: a cohort study in 2 million women. Psychol Med Bliddal M, Wesselhoeft R, Rasmussen L, Janecka M, Zaks N, Petersen LK, Egsgaard S, Jensen PB, Munk-Olsen T. PMID: 41268738 [PubMed - indexed for MEDLINE]
	Datopotamab deruxtecan versus docetaxel for non-small cell lung cancer: a plain language summary of the TROPION-Lung01 study. Future Oncol Sands J, Ahn MJ. PMID: 41268710 [PubMed - as supplied by publisher]
	Relationship between long-term outcomes and optimal time interval in patients with bilateral synchronous multiple primary lung cancers: a multi-institutional cohort study. Ann Med Guo W, Zhou B, Huai Q, Ji Y, Chen Y, He H, Han L, Li B, Zhou J, Tan F, Xue Q, Gao S, He J. PMID: 41268684 [PubMed - indexed for MEDLINE]
	Treatment-Related Adverse Events of Antibody-Drug Conjugate Monotherapy in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Thorac Cancer Li Y, Zhou L, Li S, Zhou S, Chen Y, Tong Y, Sun J, Wang L, Fan Y. PMID: 41268683 [PubMed - indexed for MEDLINE]
	Single Incision Laparoscopic Local Resection for Gastric Gastrointestinal Stromal Tumors Compared to Multiport Laparoscopic Local Resection: A Single-Center Retrospective Study. Asian J Endosc Surg Nagano S, Kitadani J, Hayata K, Goda T, Tominaga S, Fukuda N, Nakai T, Kawai M. PMID: 41268674 [PubMed - indexed for MEDLINE]
	Prehabilitation and rehabilitation guidelines for allied healthcare professionals working in head and neck cancer: a narrative review. Disabil Rehabil Baker K, Roe J, Brady G, Cruickshank S. PMID: 41268643 [PubMed - as supplied by publisher]
	Study design and rationale for the NeoTRACE trial: a multicenter phase II study of neoadjuvant sacituzumab govitecan plus zimberelimab followed by adjuvant zimberelimab with or without sacituzumab govitecan in patients with resectable non-small cell lung cancer. Future Oncol Althoff FC, Acker F, Koschade S, Heinzen S, Aguinarte L, Rost M, Schulte H, Rohde G, Winter M, Schreiner W, Krause K, Grünwald V, Serve H, Oellerich T, Sebastian M. PMID: 41268635 [PubMed - as supplied by publisher]
	Identifying risk factors for refractory tyrosine kinase inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer. Chin Clin Oncol Huang W, Ye H, Zhu Y, Huang M, Du S, Tan P. PMID: 41268624 [PubMed - as supplied by publisher]
	Role of the SOX family in nonâ€‘small cell lung cancer: Molecular mechanisms and therapeutic implications (Review). Oncol Rep Wang K, Li Y, Guo Z, Song L, Ding X, Liu L, Hu T, Bian Y, Huang C, Miao L. PMID: 41268614 [PubMed - indexed for MEDLINE]
	Metabolic, androgenic, and physical activity profiles in women aged over 40â€‰years with polycystic ovary syndrome: A comparative analysis using UK Biobank data. Womens Health (Lond) Kite C, Kyrou I, Randeva HS, Lahart IM, Brown JEP. PMID: 41268610 [PubMed - indexed for MEDLINE]
	Assessment of Some Trace Metals in Head and Neck Squamous Cell Carcinoma: A Case-Control Study. J Dent (Shiraz) Dalirsani Z, Delavarian Z, Pakfetrat A, Hashemy SI, Vazifeh Mostaan L, Khaghani F, Taherizadeh M, Shokri M, Alavi H. PMID: 41268589 [PubMed]
	A Spatial Study of Head and Neck Cancer Incidence Rate in Fars Province (the South of Iran): 2007-2020. J Dent (Shiraz) Maroufi S, Rezazadeh F, Haghighat S, Asmarian N, Kheiri A, Raeisi H, Afifian M, Banani A, Valanik S. PMID: 41268582 [PubMed]
	Overcoming resistance to immune checkpoint inhibitor in non-small cell lung cancer: the promise of combination therapy. Front Immunol Shi X, Deng W, Pan Y, Chen Y, Wang Y, Wu J. PMID: 41268560 [PubMed - indexed for MEDLINE]
	Soluble HLA-G is related to malignant melanocytic lesions and previous oncological disease may increase circulating HLA-G bearing large extracellular vesicles. Front Immunol Silva-Krebs KK, de Oliveira EM, Athayde CA, da Fonseca PB, De Felice FG, Carvalho FR, Sá Araújo M, Luz FB, Silva AA, Pantaleão L, Medeiros T, Dayse-Silva IL. PMID: 41268555 [PubMed - indexed for MEDLINE]
	Preoperative [(68)Ga]Ga-FAPI-04 PET for evaluating pathological complete response to neoadjuvant therapy in gastrointestinal adenocarcinoma patients. Front Immunol Zhang X, Feng Y, Lin Z, Chen R, Gai Y, Qin C, Lan X. PMID: 41268551 [PubMed - indexed for MEDLINE]
	Multimodal cell-cell communication driving CD8(+) T cell dysfunction and immune evasion. Front Immunol Chen L, Huang Q, Zhou P. PMID: 41268548 [PubMed - indexed for MEDLINE]
	Tislelizumab-associated toxic epidermal necrolysis in an esophageal cancer patient: a case report. Front Immunol Jin S, Liu Z, Zheng F. PMID: 41268547 [PubMed - indexed for MEDLINE]
	Advancements in extensive-stage small cell lung cancer therapy: from molecular profiling to the advent of precision oncology. Front Immunol Yang C, Shao Y, Zhang Y, Zhang H, Zhao Y. PMID: 41268540 [PubMed - indexed for MEDLINE]
	Gut microbiota and metabolites: emerging prospects in the treatment of non-small cell lung cancer. Front Immunol Jiao JM, Liu CG, Zang D, Chen J. PMID: 41268538 [PubMed - indexed for MEDLINE]
	Harnessing IgM for solid tumor therapy: biology, engineering advances, and translational challenges. Front Immunol Wang Y, Wang B, Liu S, Chen Y, Zhang S, Bu L, Zhu W, Liu X, Sun P. PMID: 41268537 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 1877835

Page 1 of 93892



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy